264 related articles for article (PubMed ID: 16575786)
21. Death-associated protein kinase localization to human renal tubule cells, and increased expression of chronic obstructive uropathy in rats.
Yukawa K; Shirasawa N; Ohshima A; Mune M; Kimura A; Bai T; Tsubota Y; Owada-Makabe K; Tanaka T; Kishino M; Tsuruo Y; Umesaki N; Maeda M
J Nephrol; 2004; 17(1):26-33. PubMed ID: 15151256
[TBL] [Abstract][Full Text] [Related]
22. Promoter hypermethylation of the death-associated protein kinase gene in breast cancer is associated with the invasive lobular subtype.
Lehmann U; Celikkaya G; Hasemeier B; Länger F; Kreipe H
Cancer Res; 2002 Nov; 62(22):6634-8. PubMed ID: 12438260
[TBL] [Abstract][Full Text] [Related]
23. DAP kinase links the control of apoptosis to metastasis.
Inbal B; Cohen O; Polak-Charcon S; Kopolovic J; Vadai E; Eisenbach L; Kimchi A
Nature; 1997 Nov; 390(6656):180-4. PubMed ID: 9367156
[TBL] [Abstract][Full Text] [Related]
24. Wnt signalling in human breast cancer: expression of the putative Wnt inhibitor Dickkopf-3 (DKK3) is frequently suppressed by promoter hypermethylation in mammary tumours.
Veeck J; Bektas N; Hartmann A; Kristiansen G; Heindrichs U; Knüchel R; Dahl E
Breast Cancer Res; 2008; 10(5):R82. PubMed ID: 18826564
[TBL] [Abstract][Full Text] [Related]
25. Death associated proteins (DAPs): from gene identification to the analysis of their apoptotic and tumor suppressive functions.
Levy-Strumpf N; Kimchi A
Oncogene; 1998 Dec; 17(25):3331-40. PubMed ID: 9916995
[TBL] [Abstract][Full Text] [Related]
26. Transcriptional silencing of hedgehog-interacting protein by CpG hypermethylation and chromatic structure in human gastrointestinal cancer.
Taniguchi H; Yamamoto H; Akutsu N; Nosho K; Adachi Y; Imai K; Shinomura Y
J Pathol; 2007 Oct; 213(2):131-9. PubMed ID: 17724792
[TBL] [Abstract][Full Text] [Related]
27. Elevated nuclear maspin expression is associated with microsatellite instability and high tumour grade in colorectal cancer.
Bettstetter M; Woenckhaus M; Wild PJ; Rümmele P; Blaszyk H; Hartmann A; Hofstädter F; Dietmaier W
J Pathol; 2005 Apr; 205(5):606-14. PubMed ID: 15714592
[TBL] [Abstract][Full Text] [Related]
28. Aberrant methylation of DAPK in long-standing ulcerative colitis and ulcerative colitis-associated carcinoma.
Kuester D; Guenther T; Biesold S; Hartmann A; Bataille F; Ruemmele P; Peters B; Meyer F; Schubert D; Bohr UR; Malfertheiner P; Lippert H; Silver AR; Roessner A; Schneider-Stock R
Pathol Res Pract; 2010 Sep; 206(9):616-24. PubMed ID: 20630662
[TBL] [Abstract][Full Text] [Related]
29. Fas-related apoptosis in gastric adenocarcinoma.
Lim SC
Oncol Rep; 2003; 10(1):57-63. PubMed ID: 12469145
[TBL] [Abstract][Full Text] [Related]
30. Promoter hypermethylation of multiple genes in early gastric adenocarcinoma and precancerous lesions.
Zou XP; Zhang B; Zhang XQ; Chen M; Cao J; Liu WJ
Hum Pathol; 2009 Nov; 40(11):1534-42. PubMed ID: 19695681
[TBL] [Abstract][Full Text] [Related]
31. DAPK promotor methylation is an early event in colorectal carcinogenesis.
Mittag F; Kuester D; Vieth M; Peters B; Stolte B; Roessner A; Schneider-Stock R
Cancer Lett; 2006 Aug; 240(1):69-75. PubMed ID: 16246486
[TBL] [Abstract][Full Text] [Related]
32. HRK inactivation associated with promoter methylation and LOH in prostate cancer.
Higuchi T; Nakamura M; Shimada K; Ishida E; Hirao K; Konishi N
Prostate; 2008 Jan; 68(1):105-13. PubMed ID: 18008329
[TBL] [Abstract][Full Text] [Related]
33. Correlation between promoter hypermethylation of GSTP1 and response to chemotherapy in diffuse large B cell lymphoma.
Nakamichi I; Tomita Y; Zhang B; Sugiyama H; Kanakura Y; Fukuhara S; Hino M; Kanamaru A; Ogawa H; Aozasa K
Ann Hematol; 2007 Aug; 86(8):557-64. PubMed ID: 17508213
[TBL] [Abstract][Full Text] [Related]
34. Urothelial carcinomas arising in arsenic-contaminated areas are associated with hypermethylation of the gene promoter of the death-associated protein kinase.
Chen WT; Hung WC; Kang WY; Huang YC; Chai CY
Histopathology; 2007 Dec; 51(6):785-92. PubMed ID: 17953697
[TBL] [Abstract][Full Text] [Related]
35. Fas ligand is up-regulated during the colorectal adenoma-carcinoma sequence.
Belluco C; Esposito G; Bertorelle R; Alaggio R; Giacomelli L; Bianchi LC; Nitti D; Lise M
Eur J Surg Oncol; 2002 Mar; 28(2):120-5. PubMed ID: 11884046
[TBL] [Abstract][Full Text] [Related]
36. CDX1 expression is reduced in colorectal carcinoma and is associated with promoter hypermethylation.
Pilozzi E; Onelli MR; Ziparo V; Mercantini P; Ruco L
J Pathol; 2004 Nov; 204(3):289-95. PubMed ID: 15378566
[TBL] [Abstract][Full Text] [Related]
37. [Hypermethylation of the death-associated protein kinase promoter in laryngeal squamous cell cancer].
Zhang S; Kong WJ
Zhonghua Zhong Liu Za Zhi; 2004 Aug; 26(8):469-71. PubMed ID: 15555335
[TBL] [Abstract][Full Text] [Related]
38. Tumor-specific adenovirus-mediated PUMA gene transfer using the survivin promoter enhances radiosensitivity of breast cancer cells in vitro and in vivo.
Wang R; Wang X; Li B; Lin F; Dong K; Gao P; Zhang HZ
Breast Cancer Res Treat; 2009 Sep; 117(1):45-54. PubMed ID: 18791823
[TBL] [Abstract][Full Text] [Related]
39. Promoter hypermethylation of death-associated protein kinase gene in cholangiocarcinoma.
Liu XF; Kong FM; Xu Z; Yu SP; Sun FB; Zhang CS; Huang QX; Zhou XT; Song ZW
Hepatobiliary Pancreat Dis Int; 2007 Aug; 6(4):407-11. PubMed ID: 17690039
[TBL] [Abstract][Full Text] [Related]
40. A novel mechanism for acquired cisplatin-resistance: suppressed translation of death-associated protein kinase mRNA is insensitive to 5-aza-2'-deoxycitidine and trichostatin in cisplatin-resistant cervical squamous cancer cells.
Bai T; Tanaka T; Yukawa K; Umesaki N
Int J Oncol; 2006 Feb; 28(2):497-508. PubMed ID: 16391806
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]